Desmopressin vs Ipamorelin
Overview
Desmopressin is primarily a hormonal peptide, while Ipamorelin is used for performance & growth.
This page compares Desmopressin and Ipamorelin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Desmopressin | Ipamorelin | |
|---|---|---|
| Category | Hormonal | Performance & Growth |
| Regulatory status (US) | FDA approved | Research use only |
| Typical dosage | 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) | 200-300 mcg |
| Frequency | Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia) | twice-daily |
| Reported benefits | central diabetes insipidus management, primary nocturnal enuresis in children, nocturia due to nocturnal polyuria, perioperative hemostasis in mild hemophilia A, hemostasis in Type I von Willebrand disease, management of polyuria following head trauma or pituitary surgery | Natural GH release, improved body composition, better sleep, anti-aging effects, no appetite increase |
| Reported side effects | hyponatremia (boxed warning), headache, facial flushing, nausea, abdominal cramps, fluid retention, hypotension, reflex tachycardia, hypertension, tachyphylaxis with repeated dosing, rare anaphylaxis | Very well-tolerated. Rare: headache, injection site reactions |
Key differences
Primary use. Desmopressin is categorised under Hormonal, while Ipamorelin falls under Performance & Growth. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Desmopressin: FDA-approved. Ipamorelin: not FDA-approved; treated as a research compound.
Dosing. Desmopressin is typically dosed at 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) (Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia)). Ipamorelin is typically dosed at 200-300 mcg (twice-daily).
Can you stack them?
Some protocols combine peptides, but stacking Desmopressin and Ipamorelin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Desmopressin and Ipamorelin?
- Desmopressin is primarily a hormonal peptide, while Ipamorelin is used for performance & growth. Desmopressin is FDA-approved for one or more indications, whereas Ipamorelin is not FDA-approved; generally classified as a research compound.
- What is Desmopressin used for?
- Synthetic ADH analog (DDAVP) FDA-approved for diabetes insipidus, nocturnal enuresis, and bleeding disorders.
- What is Ipamorelin used for?
- GH secretagogue, anti-aging.
- Can you take Desmopressin and Ipamorelin together?
- Some users combine peptides within a single protocol, but stacking Desmopressin and Ipamorelin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Desmopressin or Ipamorelin FDA-approved?
- Desmopressin is FDA-approved for one or more indications. Ipamorelin is not FDA-approved; generally classified as a research compound.
Read the full articles
- Desmopressin — full monograph: mechanism, research, dosing & references
- Ipamorelin — full monograph: mechanism, research, dosing & references